PRIMARY VECTOR
SYSTEMIC OPTIMIZATION
CLINICAL EFFICACY
DATA PENDING CLINICAL REVIEW
NCBI VERIFICATION
AWAITING PUBMED INDEX
WHAT IS IT?
Intravenous or localized injections of mesenchymal stem cells (MSCs) harvested from Wharton's jelly or bone marrow.
WHAT DOES IT DO?
Aggressively targets systemic inflammation and dynamically repairs degraded joint, tendon, and organ tissue.
HOW DO I USE IT?
Operators travel to offshore clinics for multi-day IV infusions and direct joint injections.